Status:
UNKNOWN
The Potential Role of Testosterone on Target Organ Damage in Postmenopausal Hypertensive Women
Lead Sponsor:
LanZhou University
Conditions:
Hypertension
Eligibility:
All Genders
45-65 years
Brief Summary
The incidence of CVD-related deaths is generally higher in women than men. Postmenopausal changes in estrogen/androgen ratio that induce a relative androgen excess have been proposed as important fact...
Eligibility Criteria
Inclusion
- Clinical diagnosis of hypertension
- Women are all postmenopausal
- Men are matched with women.
Exclusion
- Secondary hypertension
- Coronary disease
- Heart failure
- Arterial fibrillation
- Previous myocardial infarction
- Previous stroke
- Malignant disease
- Kidney failure
- Liver failure
- Neoplastic disease
- Severe neurological diseases
- Severe metabolic or organic decompensation
- Refuse to sign the informed consent form
Key Trial Info
Start Date :
March 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 5 2018
Estimated Enrollment :
322 Patients enrolled
Trial Details
Trial ID
NCT03451747
Start Date
March 10 2018
End Date
April 5 2018
Last Update
March 5 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.